IR Licensing and Partnerships

Latest News

June 12th 2025
GSK Licenses altSonflex1-2-3 Shigella Vaccine to Bharat Biotech

Under terms of the deal, Bharat Biotech will lead late-stage development and scale-up of the altSonflex1-2-3 Shigella vaccine for potential distribution in low- and middle-income countries.

February 13th 2025

Novartis Strikes Deal to Acquire Anthos Therapeutics

February 12th 2025

Abcuro Secures $200 Million in Series C Funding to Advance Ulviprubart for Inclusion Body Myositis

January 30th 2025

ImmunityBio, BeiGene Strike Deal to Conduct Phase III Trial for Tislelizumab, Anktiva in Advanced or Metastatic Non-Small Cell Lung Cancer